Actively Recruiting
Two Dose Levels of Privigen in Pediatric CIDP
Led by CSL Behring · Updated on 2025-10-20
30
Participants Needed
9
Research Sites
564 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A randomized, open-label, prospective, multicenter study designed to investigate 2 dose levels in pediatric subjects 2 to ≤ 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment
CONDITIONS
Official Title
Two Dose Levels of Privigen in Pediatric CIDP
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female subjects 2 to 64 17 years of age with confirmed or possible CIDP.
You will not qualify if you...
- Absence of CIDP symptoms
- History or family history of inherited neuropathy
- Diagnosed developmental delay or regression
- History of thrombotic episode
- Known or suspected hypersensitivity to Privigen
- Known allergic or other severe reactions to blood products
- Female subject of childbearing potential either not using or not willing to use a medically reliable method of contraception or not sexually abstinent during the study
- Pregnant or breastfeeding mother
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 9 locations
1
Phoenix Children's Hospital
Phoenix, Arizona, United States, 85016
Completed
2
Children's Hospital of Los Angeles
Los Angeles, California, United States, 90027
Withdrawn
3
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States, 52242-1009
Withdrawn
4
Akron Children's Hospital
Akron, Ohio, United States, 44647
Withdrawn
5
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
6
Le Bonheur Children's Hospital
Memphis, Tennessee, United States, 38105
Withdrawn
7
Neurology Rare Disease Center
Denton, Texas, United States, 76208
Actively Recruiting
8
Children's Specialty Group
Norfolk, Virginia, United States, 23507
Completed
9
Seattle Children's Hospital
Seattle, Washington, United States, 98105
Actively Recruiting
Research Team
T
Trial Registration Coordinator
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here